CCND3

(redirected from cyclin D3)

CCND3

A gene on chromosome 6p21 that encodes a member of the highly conserved cyclin family, which regulates CDK kinases. Cyclin D3 forms a complex with and is a regulatory subunit of CDK4 or CDK6, which are required for cell cycle G1/S transition. It also interacts with tumour suppressor protein Rb and is involved in its phosphorylation. The cyclin D3-CDK4 complex is involved in cell cycle progression through G2 phase into mitosis after UV light-induced damage.
References in periodicals archive ?
Antiproliferative effects were associated with a G2/M cell cycle arrest and reduced protein expression of cyclin dependent kinases (CDK) 2, 4, 6, cyclin D3, and induced expression of cyclin-dependent kinase inhibitor 2C (p18) and 1A (p21).
Accordingly, LBE treatment reduced the protein expression of cyclin dependent kinases (CDK) 2, 4, 6 and cyclin D3.
The observed ONCONASE-induced decrease in expression of cyclin D3 and an increase in expression of several inhibitors of CDKs indicate that Onconase can modulate the fundamental biological processes that become de-regulated as a result of abnormal genetic changes within cancerous cells.
The data reported showed ONCONASE inhibited the cell cycle activator cyclin D3, and also induced expression of the cell cycle inhibitor p27KIP1, which resulted in significant inhibition of tumor cell growth and proliferation.
Fiaschi-Taesch, and the team discovered that combining elevated amounts of the regulatory molecules cdk4 or cdk6 with a variety of D-cyclin proteins, particularly cyclin D3, stimulates human beta cell replication in test tubes.
Shirley, MA Cyclin D3 MGC nucleus Mouse MCA1866; 1:40 Serotec, Raleigh, NC DAPI Nucleus H-1200; Vector 1.
GNI researchers discovered that PFTK1 specifically interacted with cyclin D3 (CCND3) and formed a tri-molecular complex with the cell cycle inhibitor p21, a key tumor suppressor whose mutations are frequently found in many forms of human cancer.
PTU also altered the expression of other Wnt target genes, including multiple cyclin D3 (Ccnd3) transcripts and urokinase plasminogen activator receptor (Plau) mRNA (Table 6, Figure 3).
7) The cyclin D1-negative cases are usually positive for cyclin D2 or cyclin D3, which are occasionally expressed in other B-cell lymphomas, limiting the diagnostic usefulness of these studies.